CXCR4 and neoplasm: Targeting and blocking CXCR4 disrupts these processes, thereby blocking tumour progression, reducing resistance to chemotherapy, and supporting immunotherapies, making it a valuable focus in the development of anti-cancer strategies [47, 60, 154] (Fig. 3B).